Therapeutic Dilantin (phenytoin) levels generally range from 10 to 20 mcg/mL. Monitor blood levels regularly, typically 1-2 weeks after initiating therapy or dosage changes. Levels below 10 mcg/mL suggest inadequate seizure control, warranting a dosage increase. Conversely, levels above 20 mcg/mL indicate potential toxicity, necessitating dosage reduction.
Dosage Adjustments
Increase the daily dose by 25-50 mg, depending on the severity of the seizure activity and the extent to which the level is below the therapeutic range. Retest levels after about one week following adjustment. If the level remains subtherapeutic, repeat the increase with caution and continuous monitoring. For high levels (above 20 mcg/mL), reduce the daily dose by 25-50 mg. Closely observe for signs of toxicity, such as nystagmus, ataxia, or cognitive impairment. Remember to always follow your doctor’s guidance and adjust doses gradually.
Factors Influencing Levels
Drug interactions significantly impact Dilantin levels. Certain medications can either increase or decrease phenytoin metabolism. Your physician should carefully consider this possibility when adjusting the dose. Patient-specific factors like age, liver function, and concurrent health conditions also influence blood levels, requiring individualized dosage strategies. Regular monitoring ensures optimal therapeutic outcomes and minimizes the risk of adverse effects.
